http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1274089

Outgoing Links

Predicate Object
contentType Case Reports|Letter
endingPage 2004
issn 0939-5555
1432-0584
issueIdentifier 8
pageRange 2003-2004
publicationName Annals of Hematology
startingPage 2003
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e29ed999225cb13c857830ceb59a810a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_44443fa614e14c0af3acb594b3c1353e
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_918b034c63e18d55149234673c6cc839
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0af70639d980041f0e2f43ae400d7b75
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e83d8509132b050e540313e98be1f680
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_99960092a6453c4dfefe26096ae6e312
bibliographicCitation Jin Z, Wang Y, Wang J, Zhang J, Wu L, Wang Z. Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus. Annals of Hematology. 2019 Mar 04;98(8):2003–4. doi: 10.1007/s00277-019-03647-5.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_85b2eb658a3fec018fbd3529634163cd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b811b6900c3786c36bf7f6278006121c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2dc29df8a62ff64bc47069cb8b89c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76c5bb515c2faa08330264cd1a1de15c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74bf3cc10dff8b5d0ac2bac37fb64cb1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_850d5f3ca2dd0748b8439e075d993e8b
date 2019-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC6647074
https://doi.org/10.1007/s00277-019-03647-5
https://pubmed.ncbi.nlm.nih.gov/30830248
isPartOf https://portal.issn.org/resource/ISSN/0939-5555
https://portal.issn.org/resource/ISSN/1432-0584
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein–Barr virus
discusses http://id.nlm.nih.gov/mesh/M0007930
http://id.nlm.nih.gov/mesh/M0006695
http://id.nlm.nih.gov/mesh/M0549299
http://id.nlm.nih.gov/mesh/M0014878
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0013662
http://id.nlm.nih.gov/mesh/M0024168
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0018260

Total number of triples: 44.